These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30774720)

  • 1. Neurosteroids and oxysterols as potential therapeutic agents for glaucoma and Alzheimer's disease.
    Ishikawa M; Yoshitomi T; Covey DF; Zorumski CF; Izumi Y
    Neuropsychiatry (London); 2018; 8(1):344-359. PubMed ID: 30774720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal Degeneration and Alzheimer's Disease: An Evolving Link.
    Ashok A; Singh N; Chaudhary S; Bellamkonda V; Kritikos AE; Wise AS; Rana N; McDonald D; Ayyagari R
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurosteroids are endogenous neuroprotectants in an ex vivo glaucoma model.
    Ishikawa M; Yoshitomi T; Zorumski CF; Izumi Y
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8531-41. PubMed ID: 25406290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
    Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
    Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.
    Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A
    J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic Dysfunction in Alzheimer's Disease and Glaucoma: From Common Degenerative Mechanisms Toward Neuroprotection.
    Criscuolo C; Fabiani C; Cerri E; Domenici L
    Front Cell Neurosci; 2017; 11():53. PubMed ID: 28289378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma.
    Seki M; Lipton SA
    Prog Brain Res; 2008; 173():495-510. PubMed ID: 18929130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis.
    Luchetti S; Huitinga I; Swaab DF
    Neuroscience; 2011 Sep; 191():6-21. PubMed ID: 21514366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glaucoma: ocular Alzheimer's disease?
    McKinnon SJ
    Front Biosci; 2003 Sep; 8():s1140-56. PubMed ID: 12957857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation.
    Testa G; Staurenghi E; Zerbinati C; Gargiulo S; Iuliano L; Giaccone G; Fantò F; Poli G; Leonarduzzi G; Gamba P
    Redox Biol; 2016 Dec; 10():24-33. PubMed ID: 27687218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model.
    Zhou X; Zhang T; Wu J
    Exp Eye Res; 2019 Dec; 189():107833. PubMed ID: 31618613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer's Disease and Other Neuropsychiatric Disorders: Promising Targets in a Therapeutic Strategy.
    Żulińska S; Strosznajder AK; Strosznajder JB
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glutamate receptor-mediated retinal neuronal injury in experimental glaucoma].
    Wang ZF; Yang XL
    Sheng Li Xue Bao; 2016 Aug; 68(4):483-91. PubMed ID: 27546508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble amyloid beta oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma.
    Yin H; Chen L; Chen X; Liu X
    Med Hypotheses; 2008; 71(1):77-80. PubMed ID: 18406539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: anti-apoptosis by alpha-2-adrenergic receptor activation.
    Tatton W; Chen D; Chalmers-Redman R; Wheeler L; Nixon R; Tatton N
    Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S25-37. PubMed ID: 12852432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders.
    Louzada PR; Paula Lima AC; Mendonca-Silva DL; Noël F; De Mello FG; Ferreira ST
    FASEB J; 2004 Mar; 18(3):511-8. PubMed ID: 15003996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer's Disease.
    Gamba P; Giannelli S; Staurenghi E; Testa G; Sottero B; Biasi F; Poli G; Leonarduzzi G
    Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34067119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment.
    Loera-Valencia R; Goikolea J; Parrado-Fernandez C; Merino-Serrais P; Maioli S
    J Steroid Biochem Mol Biol; 2019 Jun; 190():104-114. PubMed ID: 30878503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease and glaucoma: mechanistic similarities and differences.
    Ghiso JA; Doudevski I; Ritch R; Rostagno AA
    J Glaucoma; 2013; 22 Suppl 5(0 5):S36-8. PubMed ID: 23733125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.